Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials.
暂无分享，去创建一个
H. Scher | M. Stöckle | D. Rathkopf | T. Flaig | K. Fizazi | C. Ryan | J. D. de Bono | T. Griffin | A. Molina | T. Kheoh | C. Ohlmann | M. Todd | J. Li | Jinhui Li | Arturo Molina | J. S. D. Bono | Charles J. Ryan | Karim Fizazi | M. Stöckle | J. S. de Bono | Thomas W. Griffin | Carsten-Henning Ohlmann | C. Ohlmann | K. Fizazi